The task of the New Materials and Supramolecular Spectroscopy research team at the Faculty of Sciences and Technology of the University of the Basque Country (UPV/EHU) has been to provide an answer to this problem by using intelligent nano-hydrogels - small particles capable of detecting diseased cells and releasing the medication only where required.
The hydrogels are polymers in the shape of a net. These hydrogels can swell up — by absorption — but cannot be dissolved in a liquid. This type of polymers has many and very diverse applications. For example, they can be used to make artificial muscle or for capturing heavy metals in waste water.
The New Materials and Supramolecular Spectroscopy research team at the Department of Physical Chemistry in the Faculty of Sciences and Technology of the UPV/EHU is a pioneering one in the investigation of hydrogels and is led by Dr. Issa A. Katime, author of the only book published in Spanish on the topic. At present, they are using hydrogels to release pharmaceutical drugs in a controlled manner, for example, with cancer patients. Their goal was to design a particle capable of detecting where the cancer is. To this end, intelligent hydrogels capable of detecting changes in pH were developed — while blood generally has a pH of 7.4, in a zone where a cancer is located it drops to 4.7-5.2. In order to achieve this capability, these hydrogels are functionalised with folic acid, which has the ability to detect and to “trick” cancer cells, in such a way that these permit penetration of their membranes: under these conditions the hydrogel acts like a “Trojan horse”. Once in the cell interior, the change in pH favours the swelling of the nano-hydrogel and, thus, the release of the pharmaceutical drug.
But known hydrogels present a problem in their application with patients: their molecular size. The most effective manner to administer a pharmaceutical drug is intravenously — it gets to all parts in a very short time —, but very large molecules cannot be injected because they may cause obstruction or problems on the organism such as, for example, angina pectoris and even heart attack. The essential condition for their use in humans is that these particles have to be sufficiently small so as not to obstruct the veins and arteries and, besides, not be detected by the white corpuscles — otherwise the latter will attack the former and cause them to enlarge, giving rise to the previously mentioned problem. Thus, if these particles are small enough to pass through the membrane of the kidney, in the case of not detecting any cancer cells, they can be excreted in the urine.The problem of size
What happens is, on synthesising polymers, particles of very different sizes are obtained. If they are to be injected into the human body, these particles cannot be much greater than 15-30 nanometres. To this end, the research team perfected a technique that not only enabled the obtaining of nanoparticles, but also that they all were of similar size.
The final design of the nanoparticles was a success. Currently these are undergoing “in vivo” trials with research teams led by Dr. José María Teijón, Professor at the Faculty of Medicine at the Complutense University in Madrid and Dr. Antonio Quintana, Professor at the Faculty of Medicine at the UPV/EHU.
But these intelligent nano-hydrogels are not only useful for combating cancer. The application of nano-hydrogels with anti-tubercular pharmaceutical drugs is currently being investigated. Today, the most effective anti-tubercular drugs have to be injected several times daily, a problem in areas with poor access to health centres, as in developing countries.
This research team is designing a system with nano-hydrogels that contains a mixture of anti-tubercular pharmaceutical drugs and which release this medication in a controlled and constant manner over long periods of time. But, in this case, the hydrogel is charged with more than one substance, and it is consequently more difficult to control the speed and concentration with which the pharmaceutical drug is released. This will oblige the team to modify the structure of the hydrogel and adapt it to suit the need of the case in hand.
Lucia Alvarez | EurekAlert!
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences